Note: Ingredients listed on restricted chemical lists
EC/CAS
207-439-9
Name of the chemical
Calcium carbonate
Concentration
≥95
EC/CAS
216-472-8
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
1-5
General Information
Version
4.2
Revision date
2023-04-26
Product name
Precipitated Nano Calcium Carbonate, coated with calcium stearate
Product Synonyms
CALOFORT® S, CALOFORT® SH, CALOFORT® SK, CALOFORT® SM, CALOFORT®SV, CALOFORT® SV14, CALOFORT® SA
1.2.1 Relevant identified uses
Calcium carbonate (powder, slurry) used by workers in industrial settings Calcium carbonate (powder, slurry) used by professional workers Consumer uses: Calcium carbonate used by consumers
Emergency telephone
+1 760 476 3961
Icons in SDS
Company Information
company name
Specialty Minerals Lifford
e-mail address of the competent person responsible for the Safety Data Sheet
cs_smil@mineralstech.com
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Other hazards which do not result in classification
Dust may cause mechanical irritation of the eyes, skin and upper respiratory tract. This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Calcium stearate (1592-23-0) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Precipitated Calcium Carbonate (471-34-1) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %